Federal contract award
75D30121C10164
TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $7.9M |
| Current contract value | $7.9M |
| Potential contract value / ceiling | $15.4M |
| Start date | Jan 1, 2021 |
| Current end date | Dec 31, 2026 |
| Potential end date | Dec 31, 2030 |
| Latest award activity | Oct 1, 2026 |
| Source loaded | Oct 17, 2026 |
Funding and modification history
Showing the latest 15 of 15 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 1, 2026 | P00014 | $-354.8K | EO 14398 |
| Jun 9, 2026 | P00013 | $0 | EO 14398 |
| Dec 17, 2025 | P00012 | $1.8M | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Dec 18, 2024 | P00011 | $1.7M | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Aug 13, 2024 | P00010 | $75.0K | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Mar 18, 2024 | P00009 | $-318.2K | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Dec 5, 2023 | P00008 | $1.5M | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Oct 20, 2023 | P00007 | $-360.3K | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Nov 4, 2022 | P00006 | $1.4M | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Jul 19, 2022 | P00004 | $0 | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Jul 13, 2022 | P00005 | $0 | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Dec 30, 2021 | P00003 | $1.3M | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Nov 1, 2021 | P00002 | $0 | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Apr 19, 2021 | P00001 | $0 | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
| Dec 18, 2020 | 0 | $1.2M | TUBERCULOSIS TRIALS AND CONSORTIUM SERVICES |
Estimated positioning window
Dec 31, 2029 – Jun 30, 2030
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2030-12-31 (1528 days from calculation)
- +5 points
- 8 historical awards in this buyer and category group
- +15 points
- 15 recorded award transactions
- +10 points
- Latest award action: 2026-10-01
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.